Quality of life among migraine patients: A cross-sectional questionnaire-based survey

Authors

  • Gopal Vishwas Esic medical college and hospital faridabad Author
  • Monica Aggarwal Department of Pharmacology, ESIC Medical College & Hospital Faridabad, India Author
  • Angelika Batta Apcer Life Sciences, Mohan Estate Author
  • Himanshu Chhabra ESIC medical college and hospital Author

DOI:

https://doi.org/10.21276/epvxt258

Keywords:

Migraine, Headache, Chronic disease, quality of life

Abstract

Background: Migraine is a chronic disorder which can negatively affects the quality of life of patients. So, we aimed to investigate the quality of life among migraine patients by conducting a questionnaire-based survey.  

Materials and Methods: This was a cross-sectional questionnaire-based study which was conducted in the Department of Pharmacology in collaboration with Department of Medicine, ESIC Medical College and Hospital, Faridabad after prior approval from the Institutional Ethics Committee. The study period was of 6 months (Feb 2019–July 2019).  100 patients suffering from migraine were enrolled, out of which 97 agreed to participate in the study. For assessment of health related quality of life (HRQol) we used the validated Migraine disability assessment (MIDAS) score and Headache Impact Test (HIT-6) score.

Results: A total of 100 migraine patients completed the questionnaire. Majority of them belonged to 31-40 years of age. Seventy-seven percent of the participants were females, and almost half of the participants (54%) reported having family history of migraine. Sixty-six percent of the participants reported being diagnosed with migraine for >5 years, and 39% reported migraine attacks ranging from 1 to 4 times/month. The most common drug used for pain during migraine attack was paracetamol (acetaminophen) (78.4%) followed by stronger analgesics like ibuprofen, mefenamic acid, naproxen etc (49%); and tryptan derivatives (26%). The most used preventive medication was amitriptyline (49%) followed by propranolol (37%).

Conclusion:  Chronic migraine has a negative impact on quality of life, predominantly in younger age of patients, patients with repeated episodes, those who are not using preventing medication and those suffering from chronic disease.

Downloads

Download data is not yet available.

References

Kvedar JC, Fogel AL, Elenko E, Zohar D. Digital medicine’s march on chronic

disease. Nature biotechnology. 2016;34(3):239.

Baksa D, Gonda X, Eszlari N, Petschner P, Acs V, Kalmar L et al. Financial

Stress Interacts With CLOCK Gene to Affect Migraine. Front BehavNeurosci.

;13:284.

AlHarbi FG, AlAteeq MA. Quality of life of migraine patients followed in

neurology clinics in Riyadh, Saudi Arabia. Journal of Family and Community

Medicine. 2020;27(1):37.

Muayqil T, Al-Jafen BN, Al-Saaran Z, Al-Shammari M, Alkthiry A, Muhammad

WS, et al. Migraine and headache prevalence and associated comorbidities in a

large Saudi sample. Eur Neurol. 2018;79:126–34.

Tayel SS. Effect of migraine headache on academic performance and quality of

life of female students at King Saud University, Kingdom of Saudi Arabia. Bull

Alex Fac Med. 2008;44:503–9.

Migraine, tension-type headache, and depression among Saudi female students

in Taif University. Desouky DE, Zaid HA, Taha AA J Egypt Public Health Assoc.

; 94(1):7.

Jumah AM, Hussein M, Khathaami AA, Kojan S, Stovner L, Steiner T. The

prevalence of primary headache disorders in Saudi Arabia. J Neurol Sci.

;333:e499.

Rajeh SA, Awada A, Bademosi O, Ogunniyi A. The prevalence of migraine and

tension headache in Saudi Arabia: A community-based study. Eur J Neurol.

;4:502–6.

AlHarbi FG, AlAteeq MA. Quality of life of migraine patients followed in

neurology clinics in Riyadh, Saudi Arabia. J Fam Community Med.

;27(1):37–45.

Al-Tulaihi BA, Al-Jumah MA. Prevalence of migraine and non-migraine

headache among high school students at the National Guard Housing in Riyadh,

Saudi Arabia. Saudi Med J. 2009 Jan;30(1):120-4.

Al Jumah M, Awada A, Al Azzam S. Headache syndromes amongst

schoolchildren in Riyadh, Saudi Arabia. Headache. 2002 Apr;42(4):281–6.

Facts and figures - The Migraine Trust [Internet]. [cited 2021 Apr 15]. Available

from: https://www.migrainetrust.org/about-migraine/migraine-what-is-it/factsfigures/

Shaik MM, Hassan NB, Tan HL, Gan SH. Quality of Life and Migraine Disability

among Female Migraine Patients in a Tertiary Hospital in Malaysia. BioMed Res

Int. 2015;2015.

Vargas LG. Gender Gap in Migraine: A Feminist Understanding of a

Complicated Health Disparity Bachelor Tucson. University of Arizona; 2019.

Bigal ME, Lipton RB. The epidemiology, burden, and comorbidities of migraine.

Neurol Clin. 2009;27:321–34.

Almalki ZA, Alzhrani MAG, Altowairqi AT, Aljawi YA, Fallatah SA, Assaedi

LM, et al. Prevalence of migraine headache in Taif City, Saudi Arabia. J Clin

Med Res. 2018;10:125–33.

Stewart WF, Linet MS, Celentano DD, Van Natta M, Ziegler D. Age-and sexspecific incidence rates of migraine with and without visual aura. Am J

Epidemiol. 1991;134:1111–20.

Hepp Z, Bloudek LM, Varon SF. Systematic review of migraine prophylaxis

adherence and persistence. J Manag Care Pharm. 2014;20:22–33.

Goadsby PJ, Sprenger T. Current practice and future directions in the prevention

and acute management of migraine. Lancet Neurol. 2010;9:285–98.

Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence

to oral migraine-preventive medications among patients with chronic migraine.

Cephalalgia. 2015;35:478–88.

Desouky DE, Zaid HA, Taha AA. Migraine, tension-type headache, and

depression among Saudi female students in Taif University. J Egypt Public

Health Assoc. 2019;94:7.

Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z. Migraine is first cause of

disability in under 50s: Will health politicians now take notice? J Headache Pain.

;19:17.

D’Amico D, Leonardi M, Grazzi L, Curone M, Raggi A. Disability and quality

of life in patients with different forms of migraine. J Headache Pain. 2015;16:A4.

Holmes WF, MacGregor EA, Sawyer JP, Lipton RB. Information about migraine

disability influences physicians’ perceptions of illness severity and treatment

needs. Headache. 2001;41:343–50.

Lipton RB, Hahn SR, Cady RK, Brandes JL, Simons SE, Bain PA, et al. In-office

discussions of migraine: Results from the American migraine communication

study. J Gen Intern Med. 2008;23:1145–51.

Buse DC, Scher AI, Dodick DW, Reed ML, Fanning KM, Manack Adams A, et

al. Impact of Migraine on the Family: Perspectives of People With Migraine and

Their Spouse/Domestic Partner in the CaMEO Study. Mayo Clin Proc. 2016 pii:

S0025-6196 (16) 00126-9.

Rutberg S, Öhrling K. Migraine-more than a headache: Women’s experiences of

living with migraine. DisabilRehabil. 2012;34:329–36.

Katsarava Z, Mania M, Lampl C, Herberhold J, Steiner TJ. Poor medical care for

people with migraine in Europe – Evidence from the Eurolight study. J Headache

Pain. 2018;19:10.

Vosoughi K, Stovner LJ, Steiner TJ, Moradi-Lakeh M, Fereshtehnejad SM,

Farzadfar F, et al. The burden of headache disorders in the Eastern Mediterranean

region, 1990-2016: Findings from the global burden of disease study 2016. J

Headache Pain. 2019;20:40.

Downloads

Published

31.12.2021

Issue

Section

ORIGINAL ARTICLES ~ Pharmacology

Similar Articles

1-10 of 272

You may also start an advanced similarity search for this article.